---
figid: PMC7028932__41416_2019_647_Fig2_HTML
figlink: pmc/articles/PMC7028932/figure/Fig2/
number: Fig. 2
caption: Overview of oncogenic pathways activated in T-ALL, the downstream signalling
  network of interleukin-7 (IL-7), NOTCH1, and polycomb repressor complex 2 (PRC2),
  and potential therapeutic targets. Binding of cytokine to the IL-7 receptor complex
  results in dimerisation of the receptor complex, which consequently phosphorylates
  JAK, as the cytokine receptor itself lacks intrinsic biological activity. Activated
  JAK1 and JAK3 induce phosphorylation of the STAT5 transcription factor, which, following
  dimerisation, translocates into the nucleus and stimulates gene expression. In addition,
  JAKs activate other downstream signalling cascades including PI3K–mTOR and RAS,
  which rationalises the use of combinations of inhibitors to promote cell death.
  STATs can also bind to the enhancer region of genes and modulate the epigenetic
  status of genes by depositing activating or repressive epigenetic marks through
  the direct recruitment of PRC2 members, histone acetyltransferases (HATs) or through
  regulation of their transcription. Abnormal NOTCH1 signalling can enhance IL-7R
  signalling. When the NOTCH1 receptor is activated in response to Delta-Serrate-Lag2
  (DSL) ligand, signalling is then mediated by intracellular NOTCH1 (ICN), which functions
  as a transcription factor. Translocation of ICN to the nucleus and recruitment of
  co-activators subsequently activates downstream gene expression. Lightning bolts
  represent the proteins that are mutated in T-ALL. Red proteins are pathway regulators.
  Potential inhibitors of the proteins and pathways are indicated. BET Bromodomain
  and Extra-Terminal motif, HAT histone acetyltransferase, HDACi histone deacetylase
  inhibitor.
pmcid: PMC7028932
papertitle: The effect of co-occurring lesions on leukaemogenesis and drug response
  in T-ALL and ETP-ALL.
reftext: Paniz Tavakoli Shirazi, et al. Br J Cancer. 2020 Feb 18;122(4):455-464.
pmc_ranked_result_index: '15997'
pathway_score: 0.9753615
filename: 41416_2019_647_Fig2_HTML.jpg
figtitle: Oncogenic pathways activated in T-ALL, the downstream signalling network
  of interleukin-7 (IL-7), NOTCH1, and polycomb repressor complex 2 (PRC2), and potential
  therapeutic targets
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7028932__41416_2019_647_Fig2_HTML.html
  '@type': Dataset
  description: Overview of oncogenic pathways activated in T-ALL, the downstream signalling
    network of interleukin-7 (IL-7), NOTCH1, and polycomb repressor complex 2 (PRC2),
    and potential therapeutic targets. Binding of cytokine to the IL-7 receptor complex
    results in dimerisation of the receptor complex, which consequently phosphorylates
    JAK, as the cytokine receptor itself lacks intrinsic biological activity. Activated
    JAK1 and JAK3 induce phosphorylation of the STAT5 transcription factor, which,
    following dimerisation, translocates into the nucleus and stimulates gene expression.
    In addition, JAKs activate other downstream signalling cascades including PI3K–mTOR
    and RAS, which rationalises the use of combinations of inhibitors to promote cell
    death. STATs can also bind to the enhancer region of genes and modulate the epigenetic
    status of genes by depositing activating or repressive epigenetic marks through
    the direct recruitment of PRC2 members, histone acetyltransferases (HATs) or through
    regulation of their transcription. Abnormal NOTCH1 signalling can enhance IL-7R
    signalling. When the NOTCH1 receptor is activated in response to Delta-Serrate-Lag2
    (DSL) ligand, signalling is then mediated by intracellular NOTCH1 (ICN), which
    functions as a transcription factor. Translocation of ICN to the nucleus and recruitment
    of co-activators subsequently activates downstream gene expression. Lightning
    bolts represent the proteins that are mutated in T-ALL. Red proteins are pathway
    regulators. Potential inhibitors of the proteins and pathways are indicated. BET
    Bromodomain and Extra-Terminal motif, HAT histone acetyltransferase, HDACi histone
    deacetylase inhibitor.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IL7
  - NOTCH1
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - PIK3R6
  - EZH2
  - SUZ12
  - PTEN
  - HSP90B1
  - TRAP1
  - HSP90AB1
  - EED
  - PTPN2
  - FBXW7
  - AKT2
  - AKT3
  - AKT1
  - MTOR
  - HRAS
  - KRAS
  - NRAS
  - ARAF
  - BRAF
  - RAF1
  - MAP2K1
  - MAP2K2
  - MAPK3
  - MAPK1
  - STAT5A
  - STAT5B
genes:
- word: IL-7
  symbol: IL-7
  source: hgnc_alias_symbol
  hgnc_symbol: IL7
  entrez: '3574'
- word: NOTCH1
  symbol: NOTCH1
  source: hgnc_symbol
  hgnc_symbol: NOTCH1
  entrez: '4851'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: JAK3
  symbol: JAK3
  source: hgnc_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: PI3K/MTORinhibitors
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K/MTORinhibitors
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K/MTORinhibitors
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K/MTORinhibitors
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K/MTORinhibitors
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K/MTORinhibitors
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K/MTORinhibitors
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K/MTORinhibitors
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: JAK1
  symbol: JAK1
  source: hgnc_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: EZH2
  symbol: EZH2
  source: hgnc_symbol
  hgnc_symbol: EZH2
  entrez: '2146'
- word: SUZ12
  symbol: SUZ12
  source: hgnc_symbol
  hgnc_symbol: SUZ12
  entrez: '23512'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: HSP-90
  symbol: HSP90
  source: bioentities_symbol
  hgnc_symbol: HSP90B1
  entrez: '7184'
- word: HSP-90
  symbol: HSP90
  source: bioentities_symbol
  hgnc_symbol: TRAP1
  entrez: '10131'
- word: HSP-90
  symbol: HSP90
  source: bioentities_symbol
  hgnc_symbol: HSP90AB1
  entrez: '3326'
- word: EED
  symbol: EED
  source: hgnc_symbol
  hgnc_symbol: EED
  entrez: '8726'
- word: PTPN2
  symbol: PTPN2
  source: hgnc_symbol
  hgnc_symbol: PTPN2
  entrez: '5771'
- word: FBXW7
  symbol: FBXW7
  source: hgnc_symbol
  hgnc_symbol: FBXW7
  entrez: '55294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: МЕК
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: МЕК
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: STAT5
  symbol: STAT5
  source: bioentities_symbol
  hgnc_symbol: STAT5A
  entrez: '6776'
- word: STAT5
  symbol: STAT5
  source: bioentities_symbol
  hgnc_symbol: STAT5B
  entrez: '6777'
chemicals: []
diseases: []
---
